 |
 |

Treatment and Prophylaxis of Seborrheic Dermatitis of the Scalp With Antipityrosporal 1% Ciclopirox Shampoo
Sam Shuster, MD;
Jean Meynadier, MD;
Helmut Kerl, MD;
Siegfried Nolting, MD
Arch Dermatol. 2005;141:47-52.
Objective To demonstrate the efficacy, safety, and tolerance of ciclopirox shampoo for treatment and prophylaxis of seborrheic dermatitis of the scalp.
Design Multicenter, randomized, double-blind, vehicle-controlled study. After treatment with ciclopirox shampoo once or twice weekly or vehicle for 4 weeks (study segment A), responders were randomized to a 12-week prophylactic study arm (segment B).
Setting Forty-five medical centers in Germany (n = 19), France (n = 15), the United Kingdom (n = 8), and Austria (n = 3).
Patients A total of 1000 patients with stable or exacerbating seborrheic dermatitis of the scalp.
Interventions A total of 949 patients were randomized to receive ciclopirox treatment once or twice weekly or vehicle for 4 weeks. Thereafter, 428 responders received either ciclopirox prophylaxis once weekly or every 2 weeks or vehicle for 3 months.
Main Outcome Measures Primary and secondary: response of "effectively treated" and "cured," with investigators and patients rating acceptability and tolerance.
Results Ciclopirox twice and once weekly produced response rates of 57.9% and 45.4%, respectively, compared with 31.6% for vehicle. Relapses occurred in 14.7% of patients using prophylactic ciclopirox once weekly, 22.1% of those in the prophylactic group shampooing once every 2 weeks, and 35.5% in the vehicle group. The few adverse events were evenly distributed among groups. Local tolerance and cosmetic acceptability were "good" in more than 85% of subjects.
Conclusions Seborrheic dermatitis of the scalp responds well to 1% ciclopirox shampoo once or twice weekly for 4 weeks. A low relapse rate is maintained by once-weekly shampooing or shampooing once every 2 weeks. These treatments are safe and well-tolerated.
Author Affiliations: Departments of Dermatology, University Hospital, Norwich, England (Dr Shuster) and Saint-Eloi Hospital, Montpellier, France (Dr Meynadier); Department of Dermatology and Venereology, Graz University Hospital, Graz, Austria (Dr Kerl); and Department of Dermatology, University of Muenster, Muenster, Germany (Dr Nolting).
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Seborrheic Dermatitis
Naldi and Rebora
NEJM 2009;360:387-396.
FULL TEXT
Evidently...
Lehman
Evid. Based Med. 2005;10:72-72.
FULL TEXT
Other articles noted
Evid. Based Med. 2005;10:95-96.
FULL TEXT
|